220 related articles for article (PubMed ID: 22205755)
1. An inducible cytochrome P450 3A4-dependent vitamin D catabolic pathway.
Wang Z; Lin YS; Zheng XE; Senn T; Hashizume T; Scian M; Dickmann LJ; Nelson SD; Baillie TA; Hebert MF; Blough D; Davis CL; Thummel KE
Mol Pharmacol; 2012 Apr; 81(4):498-509. PubMed ID: 22205755
[TBL] [Abstract][Full Text] [Related]
2. Enhancement of hepatic 4-hydroxylation of 25-hydroxyvitamin D3 through CYP3A4 induction in vitro and in vivo: implications for drug-induced osteomalacia.
Wang Z; Lin YS; Dickmann LJ; Poulton EJ; Eaton DL; Lampe JW; Shen DD; Davis CL; Shuhart MC; Thummel KE
J Bone Miner Res; 2013 May; 28(5):1101-16. PubMed ID: 23212742
[TBL] [Abstract][Full Text] [Related]
3. Intestinal and hepatic CYP3A4 catalyze hydroxylation of 1alpha,25-dihydroxyvitamin D(3): implications for drug-induced osteomalacia.
Xu Y; Hashizume T; Shuhart MC; Davis CL; Nelson WL; Sakaki T; Kalhorn TF; Watkins PB; Schuetz EG; Thummel KE
Mol Pharmacol; 2006 Jan; 69(1):56-65. PubMed ID: 16207822
[TBL] [Abstract][Full Text] [Related]
4. Abiraterone inhibits 1α,25-dihydroxyvitamin D3 metabolism by CYP3A4 in human liver and intestine in vitro.
Deb S; Chin MY; Adomat H; Guns ES
J Steroid Biochem Mol Biol; 2014 Oct; 144 Pt A():50-8. PubMed ID: 24269662
[TBL] [Abstract][Full Text] [Related]
5. Hydroxylation of 20-hydroxyvitamin D3 by human CYP3A4.
Cheng CY; Slominski AT; Tuckey RC
J Steroid Biochem Mol Biol; 2016 May; 159():131-41. PubMed ID: 26970587
[TBL] [Abstract][Full Text] [Related]
6. CYP3A4 is a human microsomal vitamin D 25-hydroxylase.
Gupta RP; Hollis BW; Patel SB; Patrick KS; Bell NH
J Bone Miner Res; 2004 Apr; 19(4):680-8. PubMed ID: 15005856
[TBL] [Abstract][Full Text] [Related]
7. Human cytochrome P450-dependent differential metabolism among three 2α-substituted-1α,25-dihydroxyvitamin D(3) analogs.
Yasuda K; Ikushiro S; Kamakura M; Takano M; Saito N; Kittaka A; Chen TC; Ohta M; Sakaki T
J Steroid Biochem Mol Biol; 2013 Jan; 133():84-92. PubMed ID: 22982757
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of 4β-Hydroxycholesterol and 25-Hydroxycholesterol as Endogenous Biomarkers of CYP3A4: Study with CYP3A-Humanized Mice.
Nitta SI; Hashimoto M; Kazuki Y; Takehara S; Suzuki H; Oshimura M; Akita H; Chiba K; Kobayashi K
AAPS J; 2018 Apr; 20(3):61. PubMed ID: 29858698
[TBL] [Abstract][Full Text] [Related]
9. Ginsenoside-mediated blockade of 1α,25-dihydroxyvitamin D3 inactivation in human liver and intestine in vitro.
Deb S; Chin MY; Adomat H; Guns ES
J Steroid Biochem Mol Biol; 2014 May; 141():94-103. PubMed ID: 24486455
[TBL] [Abstract][Full Text] [Related]
10. CYP3A4 is a vitamin D-24- and 25-hydroxylase: analysis of structure function by site-directed mutagenesis.
Gupta RP; He YA; Patrick KS; Halpert JR; Bell NH
J Clin Endocrinol Metab; 2005 Feb; 90(2):1210-9. PubMed ID: 15546903
[TBL] [Abstract][Full Text] [Related]
11. Formation of CYP3A-specific metabolites of ibrutinib in vitro is correlated with hepatic CYP3A activity and 4β-hydroxycholesterol/cholesterol ratio.
Lee J; Fallon JK; Smith PC; Jackson KD
Clin Transl Sci; 2023 Feb; 16(2):279-291. PubMed ID: 36350327
[TBL] [Abstract][Full Text] [Related]
12. Simultaneous measurement of plasma vitamin D(3) metabolites, including 4β,25-dihydroxyvitamin D(3), using liquid chromatography-tandem mass spectrometry.
Wang Z; Senn T; Kalhorn T; Zheng XE; Zheng S; Davis CL; Hebert MF; Lin YS; Thummel KE
Anal Biochem; 2011 Nov; 418(1):126-33. PubMed ID: 21784054
[TBL] [Abstract][Full Text] [Related]
13. Predicting the contribution of rat cytochrome P-450 3A1, 3A2 and human cytochrome P-450 3A4, 3A5 to territrem a 4beta-C hydroxylation using the relative activity factor.
Lin YH; Peng FC
J Toxicol Environ Health A; 2008; 71(21):1407-14. PubMed ID: 18800290
[TBL] [Abstract][Full Text] [Related]
14. Cytochrome P450 3A-mediated microsomal biotransformation of 1α,25-dihydroxyvitamin D3 in mouse and human liver: drug-related induction and inhibition of catabolism.
Deb S; Pandey M; Adomat H; Guns ES
Drug Metab Dispos; 2012 May; 40(5):907-18. PubMed ID: 22301272
[TBL] [Abstract][Full Text] [Related]
15. Human PXR-mediated induction of intestinal CYP3A4 attenuates 1α,25-dihydroxyvitamin D₃ function in human colon adenocarcinoma LS180 cells.
Zheng XE; Wang Z; Liao MZ; Lin YS; Shuhart MC; Schuetz EG; Thummel KE
Biochem Pharmacol; 2012 Aug; 84(3):391-401. PubMed ID: 22562045
[TBL] [Abstract][Full Text] [Related]
16. Roles of CYP3A4 and CYP2C19 in methyl hydroxylated and N-oxidized metabolite formation from voriconazole, a new anti-fungal agent, in human liver microsomes.
Murayama N; Imai N; Nakane T; Shimizu M; Yamazaki H
Biochem Pharmacol; 2007 Jun; 73(12):2020-6. PubMed ID: 17433262
[TBL] [Abstract][Full Text] [Related]
17. Gomisin A is a Novel Isoform-Specific Probe for the Selective Sensing of Human Cytochrome P450 3A4 in Liver Microsomes and Living Cells.
Wu JJ; Ge GB; He YQ; Wang P; Dai ZR; Ning J; Hu LH; Yang L
AAPS J; 2016 Jan; 18(1):134-45. PubMed ID: 26361765
[TBL] [Abstract][Full Text] [Related]
18. Human cytochrome P450 3A (CYP3A) mediated midazolam metabolism: the effect of assay conditions and regioselective stimulation by alpha-naphthoflavone, terfenadine and testosterone.
Mäenpää J; Hall SD; Ring BJ; Strom SC; Wrighton SA
Pharmacogenetics; 1998 Apr; 8(2):137-55. PubMed ID: 10022752
[TBL] [Abstract][Full Text] [Related]
19. Evidence for cytochrome P450 2A6 and 3A4 as major catalysts for N'-nitrosonornicotine alpha-hydroxylation by human liver microsomes.
Patten CJ; Smith TJ; Friesen MJ; Tynes RE; Yang CS; Murphy SE
Carcinogenesis; 1997 Aug; 18(8):1623-30. PubMed ID: 9276639
[TBL] [Abstract][Full Text] [Related]
20. The serum vitamin D metabolome: What we know and what is still to discover.
Tuckey RC; Cheng CYS; Slominski AT
J Steroid Biochem Mol Biol; 2019 Feb; 186():4-21. PubMed ID: 30205156
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
